Oncology / Radiation Therapy - Related Articles

The articles below have been published in peer-reviewed journals. To read about our Oncology patients or watch videos about our Oncology patients, please visit www.vetcancerspecialists.com.

Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid-peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma

Kimberly A. Statham-Ringen, DVM, et al. AJVR, Vol 73, No 5, May 2012

A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs

DM Vail, H von Euler, AW Rusk, L Barber, C Clifford, R Elmslie, et al. J Vet Intern Med, 2012 March: 1-10

Interleukins: biological properties and therapeutic potential

R Elmslie, et al. Journal of Veterinary Internal Medicine September 1991, 5(5):283–293.

Radiotherapy with and without chemotherapy for localized lymphoma in 10 cats

R Elmslie, et al. Veterinary Radiology November 1991, 32(6 ):277–280.

In vivo tumor transfection with super antigen plus cytokine genes induces tumor regression and pr longs survival in dogs with malignant melanoma.

SW Dow, R Elmslie, AP Willson, et al. J Clin Invest. June 1, 1998, 101(11): 2406-2414.

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases.

SW Dow, R Elmslie, LG Fradkin, et al. Gene Therapy. December 1999, 10(18): 2961-2972.

Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases

Steven Dow, R Elmslie, et al. HUMAN GENE THERAPY August 2005, 16:1-10.

Liposome–DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma

D Kamstock, A Guth, R Elmslie, et al. Cancer Gene Therapy (2006) 13, 306–317.

Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer

B.J. Biller, R Elmslie, et al. Veterinary Immunology and Immunopathology 116 (2007) 69–78.

Doxorubicin and BAY 12–9566 for the Treatment of Osteosarcoma in Dogs: A Randomized, Double-Blind, Placebo-Controlled Study

Antony S. Moore, William S. Dernell GK Ogilvie, O Kristal, R Elmslie, et al. Journal of Veterinary Internal Medicine. July 2007, 21(4): 783–790.

Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma

LW U’Ren, BJ Biller, R Elmslie, et al. Journal of Veterinary Internal Medicine January 2007, 21(1), pages 113–120

Continuous Low-Dose Oral Chemother apy for Adjuvant Therapy of Splenic Hemangiosar coma in Dogs

S Lana, L U’Ren, S Plaza, R Elmslie, et al. Journal of Veterinary Internal Medicine July 2007, 21(4) :764–769

Metronomic Therapy with Cyclophosphamide and Piroxicam Effectively Delays Tumor Recurrence in Dogs with Incompletely Resected Soft Tissue Sarcomas

R Elmslie, et al. J Vet Intern Med 2008; 22:1373–1379.

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma

D Kamstock, R Elmslie, et al., Cancer Immunology, 2007, 56 (8):1299-1309.

Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs

S Hafeman, C London, R Elmslie et al. Cancer Immunology, Immunotherapy March 2010, 59(3): 441-452.

Canine Lingual Lymphoma: A Retrospective Review of 8 Cases (2000-2010)

BM Twigg, CJ Henry, TA Rocha, R Elmslie, et al. Veterinary Cancer Society Proceedings Nov. 2010, San Diego, pp:67.

Molecular Imaging of the bcl-2 Oncogene in Canine B-Cell Lymphoma

Statham (Ringen) K, Green JA, Selting KA, Lattimer J, Bryan JN, Villamil JA, Henry CJ, Lewis MR. Proceedings of the 28th Veterinary Cancer Society Annual Conference, Seattle, WA, October 18-21 2008, 28.

Clinical Assessment of the Petscreen Proteomic Identification Profile for Canine Lymphoma

Villamil JA, Slater K, Statham (Ringen) K, Tyler J, Ratcliffe L, Shahid M, Mobasheri A, Henry CJ. Proceedings of the 28th Veterinary Cancer Society Annual Conference, Seattle, WA, October 18-21 2008, 11.

Comparison of Somatostatin Analogues and Conventional Imaging Modalities for Staging of Canine B-Cell Lymphoma

Ringen KS, Selting KA, Lattimer J, Bryan JN, Villamil JA, Henry CJ, Lewis MR. Proceedings of the 29th Veterinary Cancer Society Annual Conference, Austin, TX, October 16-19 2009, 13.

Molecular Imaging of Canine B-cell Lymphoma Using an Anti-bcl-2 Peptide Nucleic Acid-Peptide Conjugate

Ringen KS, Selting KA, Lattimer J, Bryan JN, Henry CJ, Green J, Jia F, Lewis MR. American Journal of Veterinary Research, (In press) 2011.

Click Here For Emergency Care Referring Veterinarians Click Here